Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

http://www.wikidata.org/entity/Q33562931

about

Influence of hypoxia in inflammatory synovitis.Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.Periarticular bone loss in antigen-induced arthritis.Etanercept: therapeutic use in patients with rheumatoid arthritis Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.Fibrocyte activation in rheumatoid arthritis Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis.The disablement process in rheumatoid arthritis.Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.Current imaging strategies in rheumatoid arthritis CD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice.Beyond the joints in rheumatoid arthritis: Effects of adalimumab on hematologic and lipid indices Early Prognostic Factors Associated with the Efficacy of Infliximab Treatment for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate.Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis.A systematic review of the influence of anti-TNF on infection rates in patients with rheumatoid arthritis.Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.GADD45γ regulates TNF-α and IL-6 synthesis in THP-1 cells.Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis.Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytoki Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay.Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion Optimized "in vitro" culture conditions for human rheumatoid arthritis synovial fibroblasts.Inhibitory effects of EGb761 on the expression of matrix metalloproteinases (MMPs) and cartilage matrix destruction.Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus.Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.TNF-α modulates expression of the circadian clock gene Per2 in rheumatoid synovial cells.Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.Inflammatory genes TNFα and IL6 display no signs of increased H3K4me3 in circulating monocytes from untreated rheumatoid arthritis patients.A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis.Responses of normal and rheumatic human articular chondrocytes cultured under various experimental conditions in agarose.Lipopolysaccharide accelerates collagen-induced arthritis in association with rapid and continuous production of inflammatory mediators and anti-type II collagen antibody.Fragile X-related protein FXR1 controls post-transcriptional suppression of lipopolysaccharide-induced tumour necrosis factor-alpha production by transforming growth factor-beta1.

P2860

Q33539669-AA87F7CF-6422-44D1-8F08-27BE41221F04 Q33564673-44CA5072-B938-4529-B70B-42DBB85CB9B5 Q33564938-774229A7-D3FC-4119-A029-4E8B618BFD5A Q33661693-EB1031C8-C75C-4DB1-B08D-527FD7E0EDF9 Q33782355-191FFC4E-9159-4D19-9D69-5C1E13F52866 Q33893095-932A9197-CDFB-42D9-AD55-0717D062E794 Q34019284-263E655F-3134-4BCC-B67D-0A744E202F5A Q34383596-6B2BE10C-85C9-4D21-AF9A-43709247DFF1 Q34468474-E3BA668D-C3C9-45CF-B56F-9A0D9B01DAFD Q34736462-6EA71DCF-C83D-441A-A6A2-4D0EFACBE63B Q34896320-7AB4822E-A3D7-4473-9A31-8640E175DFC4 Q35012157-31657EEA-A36F-4779-BA64-E1C6F091DC01 Q35176993-DC76D9A5-5354-48E1-8E99-3ADB50138D13 Q35549328-19789ABB-7B8D-45CF-80CF-57152D654D39 Q35777047-6F756A41-28E7-4FFF-A20D-380CB660FC2C Q36337258-D10E5511-6AE7-4638-96B6-7D2FDDED878A Q36543020-8B276FF6-F281-472E-B8A9-0F79281B3264 Q37064901-02625E20-FE49-4EF9-911F-9E93F789D73A Q37208439-80FD9157-749F-47A1-A18F-697FD1F21B53 Q37577348-C1E535B3-3441-4739-9270-6146079CD11F Q38183297-C1B3D2EC-D232-4615-8CBB-2F14433A529D Q38461240-77F8F495-0708-4851-A985-30ADF533718E Q39321571-AA8400D1-6436-4A64-8965-7ABA1187BEA7 Q39502368-1F2DB14A-F13D-4DBF-B1F3-1E7979112D3B Q39547833-6CB77C80-7435-4ED0-A545-BD2E3B2D1FFE Q39806745-44872727-075B-41A2-894F-3EB797294636 Q40172737-9E4DCFB8-B93F-4176-8ABA-C1D161D7C042 Q41282394-2C6A5BC3-D3A2-41F2-91E2-F5C0457D70CD Q41687175-7316EBEE-F712-4312-BCC3-E2601E78AC85 Q42022447-F192DCC9-1595-4313-BFC7-3851052D0696 Q42184532-CF2B82CA-BAB0-401E-9DCD-223666DD29E7 Q42481349-E5D50C5C-EC4C-42CD-95C5-62668BCC716F Q42643514-0D6E7278-A72D-4880-8EF6-CBED0C60E05D Q43518522-0351F62C-BE7A-4615-8985-F6F45E2024C9 Q44974517-357F7065-F740-4B49-8F08-487ECA995E8A Q47970864-C45ECB85-F81B-44C5-B65B-5825C0979524 Q50079741-DFEF8759-D9A5-4424-BAAE-570E727011F7 Q50874394-BBDC009D-B3EE-4D75-A96E-2AF1C054FF6F Q50902178-DB95F2A9-72B8-40C6-A695-01F87026E2F2 Q51850846-FDED965A-2448-486B-A47E-B50448039F82

P2860

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

http://www.wikidata.org/entity/Q33562931

description

1990 nî lūn-bûn

@nan

1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@ast

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@en

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@nl

type

label

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@ast

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@en

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@nl

prefLabel

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@ast

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@en

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@nl

P1433

Q33562931-6A5C8CB9-CA55-4DB5-A6FF-6F52FC5EEA57

P1476

Q33562931-9D1D957A-3643-4A9A-AF1B-4BE4F7631E23

P2093

Q33562931-0EF11E73-C9A6-49B5-8264-FF3C498DE7AE

Q33562931-BAE10BC5-EA58-456F-B1DF-AD66D6C42DFD

Q33562931-CFF18754-9266-4F7A-99E1-552B9612440F

Q33562931-DF5B98FA-1F26-478D-959A-E424B3C313B8

P2860

Q33562931-0A1F5941-FB77-46A3-87AF-8F10348DA1A5

Q33562931-0B24DA96-2AEF-45F9-8269-911D9E8CB953

Q33562931-14A7C445-A705-48F6-A6E7-B00854601DF9

Q33562931-4DF4ED67-B035-4A85-B58B-88251F5AC090

Q33562931-675E2B68-3457-4440-B954-FB94AFDCE08B

Q33562931-6BF009D6-2084-4C3F-B8F1-5E3027816DE5

Q33562931-837305C6-2034-4F10-B97C-E21A15146C1E

Q33562931-93D66F4F-CFA1-4D53-8FB9-282C50466D5E

Q33562931-95B2091E-B8BC-4F99-AA75-012BDA620449

Q33562931-A354D2D5-DCE5-4A30-9795-7FEE1D14E201

P304

Q33562931-2AD4BBE3-0A90-43F0-A155-3E68139844C9

P31

Q33562931-3F4F013D-46F2-4BF3-A97F-D07F9B3F12DF

P356

Q33562931-D0F45BC1-8C4A-4327-A5B3-62628FB72A5A

P407

Q33562931-69871B1F-FD78-45BB-9B10-6BA70CD1D6D6

P433

Q33562931-46AE3D3F-C20D-45A0-BA90-875031EEF927

P478

Q33562931-0AF7930D-FFDD-4050-9AD1-3C0F0B5EB177

P50

Q33562931-046BAEC9-5B97-46E6-B9DB-D2DE290B2994

P577

Q33562931-45CE2957-D920-4545-A6DF-FC5BA45D3CF8

P5875

Q33562931-389428A9-0573-49B9-ACCB-682E1DA34E2B

P698

Q33562931-3EF386E4-B1FE-4DB9-91B8-2C354D157A3C

P921

Q33562931-9f8d353a-0787-4abd-ab8f-72731c59f4b2

Q33562931-EEF25821-0272-4FBA-95FE-BA9FDEFFDE14

P932

Q33562931-771F1E57-619D-4F66-BD83-F10227638AC3

P356

P1433

Annals of the Rheumatic Diseases

P1476

Tumour necrosis factor in seru ...... d severe rheumatoid arthritis.

@en

P2093

C Baglioni

http://www.w3.org/2001/XMLSchema#string

C Di Vittorio

http://www.w3.org/2001/XMLSchema#string

C Tetta

http://www.w3.org/2001/XMLSchema#string

V Modena

http://www.w3.org/2001/XMLSchema#string

P2860

An endotoxin-induced serum factor that causes necrosis of tumors

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro.

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Cachectin: more than a tumor necrosis factor.

P304

665-667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.49.9.665

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Camussi

P577

1990-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21454452

http://www.w3.org/2001/XMLSchema#string

P698

1700672

http://www.w3.org/2001/XMLSchema#string

P921

P932

1004199

http://www.w3.org/2001/XMLSchema#string